A human factor IX slow release dosage form is disclosed. Said dosage form comprises therapeutically effective amount of human factor IX which is encapsulated with lipophilic biodegradable polymer or copolymer to obtain microspheres in form of powder. Said dosage form is able to release the human factor IX slowly and prolong its biological activity.